Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-10

Clinical Trial Update: Effects of Hemp-Derived Cannabinoids on Menopause Symptoms [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Washington State University is evaluating the effects of hemp-derived cannabinoids on menopause and perimenopause symptoms…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hemp-derived cannabinoids (cannabinoids derived from hemp)

Snippet

Sponsor: Washington State University | Conditions: Menopause, Perimenopause | Phase 2 | Status: RECRUITING